| scholarly article | Q13442814 |
| P2093 | author name string | B. K. Murray | |
| P. S. Morahan | |||
| J. G. Tew | |||
| E. N. Kitces | |||
| P2860 | cites work | Cyclic Appearance of Defective Interfering Particles of Herpes Simplex Virus and the Concomitant Accumulation of Early Polypeptide VP175 | Q31095616 |
| Evidence that neurons harbor latent herpes simplex virus | Q34108496 | ||
| New adjuvants on a polymethylmethacrylate base | Q34385637 | ||
| Stimulation of rabies vaccine in mice by low doses of polyadenylic:polyuridylic complex | Q34477020 | ||
| Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection | Q34483710 | ||
| THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAINING | Q36266931 | ||
| Oncogenic transformation of hamster embryo cells after exposure to inactivated herpes simplex virus type 1. | Q36592033 | ||
| Experimental evidence for the oncogenic potential of herpes simplex virus | Q36861900 | ||
| Herpesvirus type 2-related antigens and their relevance to humoral and cell-mediated immunity in patients with cervical cancer | Q36861940 | ||
| Infection with herpes-simplex viruses 1 and 2. 3. | Q39898637 | ||
| Latent Infection of Sensory Ganglia with Herpes Simplex Virus: Efficacy of Immunization | Q39934802 | ||
| Humoral and Cellular Immune Responses to an Envelope-Associated Antigen of Herpes Simplex Virus | Q39963205 | ||
| Correlation of tumor burden with in vitro lymphocyte reactivity and antibodies to herpesvirus tumor-associated antigens in head and neck squamous carcinoma | Q39973124 | ||
| Studies on herpes simplex virus and cancer | Q39978368 | ||
| Comparative Diagnostic Aspects of Herpes Simplex Virus Tumor-Associated Antigens2 | Q40021644 | ||
| Latent herpes simplex virus in spinal ganglia of mice | Q44563203 | ||
| Recovery of herpes simplex virus from human sacral ganglions | Q45818011 | ||
| Transformation of hamster embryo and human embryo cells by temperature sensitive mutants of herpes simplex virus type 2. | Q45818097 | ||
| Early and late viral-specific polyribosomal RNA in herpes virus-1 and -2-infected rabbit kidney cells | Q45818133 | ||
| Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy | Q45818459 | ||
| Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2. | Q45821420 | ||
| Herpes simplex vaccines | Q66703795 | ||
| [Experience with the diagnostic and therapeutic use of herpetic polyvaccine] | Q68641992 | ||
| Isolation of herpesviruses from trigeminal ganglia of man, monkeys, and cats | Q68666540 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbiology | Q7193 |
| immunology | Q101929 | ||
| vaccine | Q134808 | ||
| attenuated vaccine | Q1810913 | ||
| viral antigens | Q66058032 | ||
| P304 | page(s) | 955-960 | |
| P577 | publication date | 1977-06-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine | |
| P478 | volume | 16 |
| Q53941528 | Animal studies on the efficacy of vaccination against recurrent herpes. |
| Q36432263 | Antibody responses in humans to individual proteins of herpes simplex viruses |
| Q40183404 | Comparison of effects of adjuvants on efficacy of virion envelope herpes simplex virus vaccine against labial infection of BALB/c mice |
| Q36480049 | Effect of Pyran on Latency After Herpes Simplex Virus Infections |
| Q52851422 | Efficacy of a nucleic acid free herpetic subunit vaccine. |
| Q45801958 | Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice |
| Q45850884 | Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2. |
| Q45275287 | Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection. |
| Q33641432 | Experimental ulcerative herpetic keratitis. IV. Preliminary observations on the efficacy of a herpes simplex subunit vaccine |
| Q37099580 | Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2. |
| Q34139375 | Herpes simplex viruses: is a vaccine tenable? |
| Q72956055 | Immune response to a DNA free herpes simplex vaccine in man |
| Q40616009 | Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections |
| Q36422499 | Immune responses to labial infection of BALB/c mice with herpes simplex virus type 1. |
| Q40278840 | Immunogenicity of subviral herpes simplex virus preparations. I. Formation of neutralizing antibodies in different animal species after administration of herpes simplex virus solubilized antigens |
| Q69361296 | Latent HSV-1 infection in mice immunized with a zwitterionic detergent-extracted HSV-1 antigen preparation |
| Q34433035 | Orofacial Herpes Simplex Virus Infection in Hairless Mice: Latent Virus in Trigeminal Ganglia After Topical Antiviral Treatment |
| Q45803445 | Prepubertal vaccination of mice against experimental infection of the genital tract with type 2 herpes simplex virus |
| Q40081296 | Prevention of herpes simplex virus diseases in man |
| Q40161394 | Protective effect of an oral infection with Herpes simplex virus type 1 against subsequent genital infection with Herpes simplex virus type 2 |
| Q45801490 | Protectivity of herpes simplex virus antigens: studies in mice on the adjuvant effect of PICLC and on the dependence of protection on T cell competence |
| Q41646450 | Report of twelve years experience in open study of Skinner herpes simplex vaccine towards prevention of herpes genitalis |
| Q45801486 | The influence of different modes of immunization on the experimental genital herpes simplex virus infection of mice |
| Q40104231 | The pathogenesis of acute, latent and recurrent herpes simplex virus infections |
| Q38020832 | Viral Vaccines under Development: A Third Generation |
| Q69821212 | Zwitterionic detergent solubilisation of HSV-1 surface antigens |
Search more.